金域医学
(603882)
| 流通市值：134.96亿 | | | 总市值：135.87亿 |
| 流通股本：4.60亿 | | | 总股本：4.63亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,442,660,458.1 | 2,177,060,105.01 | 1,987,068,521.84 | 2,433,585,245.93 |
| 应收票据及应收账款 | 3,827,036,361.93 | 4,120,803,795.2 | 4,323,301,026.46 | 4,396,328,960.56 |
| 其中：应收票据 | 200,000 | 10,024,044.46 | 2,024,044.46 | - |
| 应收账款 | 3,826,836,361.93 | 4,110,779,750.74 | 4,321,276,982 | 4,396,328,960.56 |
| 预付款项 | 14,154,016.54 | 9,267,774.62 | 9,965,125.98 | 8,456,672.67 |
| 其他应收款合计 | 85,433,737.69 | 78,722,135.67 | 77,887,867.45 | 82,706,292.5 |
| 存货 | 190,612,298.75 | 190,723,447.57 | 192,573,285.14 | 198,315,250.59 |
| 合同资产 | 63,867,755.79 | 20,427,003.08 | 62,495,947.25 | 32,842,943.92 |
| 其他流动资产 | 104,105,419.96 | 107,561,319.53 | 165,236,560.62 | 166,002,184.12 |
| 流动资产合计 | 6,727,870,048.76 | 6,704,565,580.68 | 6,818,528,334.74 | 7,318,237,550.29 |
| 非流动资产: | | | | |
| 长期股权投资 | 122,690,595.26 | 174,795,453.87 | 173,768,125.72 | 174,512,921.41 |
| 其他非流动金融资产 | 280,826,645.58 | 283,350,518.25 | 248,278,859.73 | 250,517,052.87 |
| 投资性房地产 | 18,390,437.76 | 25,332,297.14 | 25,606,123.89 | 28,239,029.36 |
| 固定资产 | 1,086,694,814.42 | 1,132,239,035.29 | 1,190,537,730.48 | 1,255,918,382.21 |
| 在建工程 | 634,246,042.81 | 628,999,197.35 | 566,720,804.81 | 527,946,479.59 |
| 使用权资产 | 158,293,133.99 | 170,762,079.44 | 176,734,290 | 184,579,346.84 |
| 无形资产 | 173,806,569.81 | 163,628,455.56 | 164,825,893.95 | 167,539,417.87 |
| 开发支出 | 5,890,702.67 | 5,093,805.62 | 4,236,639.48 | 3,354,408.43 |
| 商誉 | 52,205,371.01 | 52,205,371.01 | 52,205,371.01 | 52,205,371.01 |
| 长期待摊费用 | 133,281,404.68 | 146,073,051.92 | 163,168,149.07 | 181,381,008.46 |
| 递延所得税资产 | 301,670,931.82 | 287,067,948.89 | 261,187,627.76 | 241,420,294.68 |
| 其他非流动资产 | 18,039,112.27 | 9,392,486.44 | 9,111,965.52 | 6,042,479.47 |
| 非流动资产合计 | 2,986,035,762.08 | 3,078,939,700.78 | 3,036,381,581.42 | 3,073,656,192.2 |
| 资产总计 | 9,713,905,810.84 | 9,783,505,281.46 | 9,854,909,916.16 | 10,391,893,742.49 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 1,001,000 |
| 应付票据及应付账款 | 1,560,749,315.53 | 1,693,079,630.77 | 1,668,436,320.77 | 1,716,135,933.64 |
| 应付账款 | 1,560,749,315.53 | 1,693,079,630.77 | 1,668,436,320.77 | 1,716,135,933.64 |
| 合同负债 | 67,951,017.91 | 63,441,467.13 | 74,575,820.29 | 54,839,127.4 |
| 应付职工薪酬 | 152,235,721.96 | 130,725,704.9 | 139,366,559.78 | 185,226,374.53 |
| 应交税费 | 64,598,250.24 | 39,415,825.12 | 58,675,286.88 | 72,657,926.86 |
| 其他应付款合计 | 86,988,849.34 | 91,972,363.69 | 101,434,074.37 | 88,145,017.87 |
| 一年内到期的非流动负债 | 209,022,236.86 | 153,781,381.86 | 104,411,746.86 | 114,071,742.11 |
| 其他流动负债 | 354,417.43 | 278,333.76 | 322,932.78 | 337,997.15 |
| 流动负债合计 | 2,141,899,809.27 | 2,172,694,707.23 | 2,147,222,741.73 | 2,232,415,119.56 |
| 非流动负债: | | | | |
| 长期借款 | 474,607,743.47 | 509,032,743.47 | 533,967,017.36 | 514,934,565.81 |
| 租赁负债 | 103,197,604.24 | 109,503,589.3 | 109,920,448.16 | 118,386,366.02 |
| 递延收益 | 17,656,683.01 | 18,699,157.75 | 19,761,055.56 | 22,379,444.34 |
| 递延所得税负债 | 22,771,878.05 | 25,509,599.29 | 26,593,684.45 | 28,705,653.71 |
| 非流动负债合计 | 618,233,908.77 | 662,745,089.81 | 690,242,205.53 | 684,406,029.88 |
| 负债合计 | 2,760,133,718.04 | 2,835,439,797.04 | 2,837,464,947.26 | 2,916,821,149.44 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 463,258,275 | 463,258,275 | 463,258,275 | 463,258,275 |
| 资本公积 | 1,169,645,248.52 | 1,171,063,209.99 | 1,171,063,209.99 | 1,171,063,209.99 |
| 其他综合收益 | 28,521,424.3 | 28,388,879.5 | 34,726,201.64 | 36,660,565.63 |
| 盈余公积 | 234,385,637.5 | 234,385,637.5 | 234,385,637.5 | 234,385,637.5 |
| 未分配利润 | 4,932,625,436.28 | 4,927,428,147.75 | 4,984,449,722.15 | 5,419,902,259.03 |
| 归属于母公司股东权益合计 | 6,828,436,021.6 | 6,824,524,149.74 | 6,887,883,046.28 | 7,325,269,947.15 |
| 少数股东权益 | 125,336,071.2 | 123,541,334.68 | 129,561,922.62 | 149,802,645.9 |
| 股东权益合计 | 6,953,772,092.8 | 6,948,065,484.42 | 7,017,444,968.9 | 7,475,072,593.05 |
| 负债和股东权益合计 | 9,713,905,810.84 | 9,783,505,281.46 | 9,854,909,916.16 | 10,391,893,742.49 |
| 公告日期 | 2025-10-30 | 2025-08-23 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |